1. P478: THE GERMLINE VARIANT GFI1-36N PROMOTES GENETIC INSTABILITY IN LEUKEMIC CELLS AND OPENS NEW THERAPEUTIC APPROACHES FOR ABOUT 15% OF ALL AML PATIENTS. (23rd June 2022) Authors: Vorwerk, J.; Frank, D.; Sun, K.; Neumannn, F.; Heuser, M.; Kunadt, D.; Berdel, W. E.; Mikesch, J.-H.; Schliemann, C.; Lenz, G.; Jayavelu, A. K.; Khandanpour, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗